Nature Medicine Features KineMed, Inc.'s Fibrosis Research, Which Aims to Advance Therapeutics for the Underlying Cause of 45% of All Deaths

Published: Jan 20, 2011

(BUSINESS WIRE)--KineMed Inc.’s (www.kinemed.com) fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

Back to news